Cargando…

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive primary malignancy in adults with high aggression. The prognosis of GBM patients is poor. There is a critical need for novel biomarkers for the prognosis and therapy of GBM. METHODS: Differentially expressed genes (DEGs) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hao, Wang, Di, Yi, Bolong, Cai, Heng, Xi, Zhuo, Lou, Xin, Li, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363458/ https://www.ncbi.nlm.nih.gov/pubmed/34395626 http://dx.doi.org/10.1155/2021/8357585

Ejemplares similares

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma
por: Zhang, Hao, et al.
Publicado: (2022)

Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme
por: Ma, Yawen, et al.
Publicado: (2022)

Correlation of APE1 with VEGFA and CD163(+) macrophage infiltration in bladder cancer and their prognostic significance
por: Wang, Lin-Ang, et al.
Publicado: (2020)

Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme
por: Yang, Yuling, et al.
Publicado: (2023)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
Publicado: (2018)

Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
por: Huang, Xiaopei, et al.
Publicado: (2018)

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
por: Chen, Anjing, et al.
Publicado: (2022)

Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016)

CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
por: Kather, Jakob Nikolas, et al.
Publicado: (2019)

T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme
por: Qi, Chunxiao, et al.
Publicado: (2021)

PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
por: Qiao, Hao, et al.
Publicado: (2023)

GBE1 Is an Independent Prognostic Marker and Associated With CD163(+) Tumor-Associated Macrophage Infiltration in Lung Adenocarcinoma
por: Liang, Yicheng, et al.
Publicado: (2022)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Development of an Immune Infiltration-Related Prognostic Scoring System Based on the Genomic Landscape Analysis of Glioblastoma Multiforme
por: Tang, Guihua, et al.
Publicado: (2020)

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics
por: Li, Rui, et al.
Publicado: (2015)

Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
por: Ye, Yintao, et al.
Publicado: (2023)

mTOR Modulates Intercellular Signals for Enlargement and Infiltration in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

High Infiltration of CD68(+)/CD163(−) Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
por: Svensson, Maria C., et al.
Publicado: (2022)

Prognostic value of tumor-infiltrating CD163(+)macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment
por: Kinoshita, Jun, et al.
Publicado: (2022)

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia
por: Polivka, J., et al.
Publicado: (2014)

Evaluating the Prognostic Accuracy of Biomarkers for Glioblastoma Multiforme Using The Cancer Genome Atlas Data
por: Hu, Nan, et al.
Publicado: (2017)

TSPAN4 is a prognostic and immune target in Glioblastoma multiforme
por: Zheng, Yue, et al.
Publicado: (2023)

Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
por: Xue, Tao, et al.
Publicado: (2021)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages
por: Hu, Wan-Ming, et al.
Publicado: (2020)

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017)

Genomic and Epigenomic Features of Glioblastoma Multiforme and its Biomarkers
por: Jadoon, Sarmad Sheraz, et al.
Publicado: (2022)

Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA
por: Winkelmaier, Garrett, et al.
Publicado: (2023)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme
por: Yin, Jun, et al.
Publicado: (2020)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis
por: Li, Hao, et al.
Publicado: (2021)

Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018)

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme
por: Aisa, Adilai, et al.
Publicado: (2022)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gtl9t2q9cfl5o7jq5nmagr3o36